Needham & Company LLC Reiterates "Hold" Rating for ICU Medical (NASDAQ:ICUI)

ICU Medical (NASDAQ:ICUI - Get Free Report)'s stock had its "hold" rating reissued by analysts at Needham & Company LLC in a note issued to investors on Tuesday,Benzinga reports.

A number of other equities analysts have also weighed in on the company. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target for the company in a research report on Wednesday, December 11th. Raymond James set a $97.00 target price on shares of ICU Medical in a research report on Wednesday, March 12th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Friday, April 4th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $168.67.

ICU Medical Price Performance

Shares of ICUI traded up $4.22 during trading hours on Tuesday, hitting $142.65. 318,377 shares of the company were exchanged, compared to its average volume of 269,086. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The company has a market capitalization of $3.50 billion, a PE ratio of -31.21 and a beta of 0.86. The firm has a fifty day simple moving average of $148.29 and a 200-day simple moving average of $160.95. ICU Medical has a one year low of $93.36 and a one year high of $196.26.

Remove Ads

Hedge Funds Weigh In On ICU Medical

Several institutional investors and hedge funds have recently bought and sold shares of ICUI. Arizona State Retirement System boosted its holdings in shares of ICU Medical by 1.0% during the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock worth $1,044,000 after purchasing an additional 65 shares during the period. Huntington National Bank lifted its position in ICU Medical by 6.2% in the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock worth $218,000 after buying an additional 82 shares in the last quarter. Equitable Trust Co. boosted its stake in shares of ICU Medical by 1.6% during the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock valued at $822,000 after buying an additional 84 shares during the period. LPL Financial LLC grew its holdings in shares of ICU Medical by 2.0% during the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock valued at $747,000 after acquiring an additional 93 shares in the last quarter. Finally, Alliancebernstein L.P. increased its stake in shares of ICU Medical by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock worth $4,051,000 after acquiring an additional 136 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.